Physicians appear to be restricting their contact with pharmaceutical representatives, according to recent data from Capgemini Consulting, the strategy and transformation brand of Paris-based ...

Are pharma reps on balance a curse or a blessing to medical practices? On some days it is not unusual to believe the former, that the pharmaceutical representative is another obnoxious intrusion into ...

Is the benefit to your medical group of maintaining ongoing relationships with pharma reps worth the cost? That’s a question confronting thousands of hospitals and medical groups today. Many factors ...

Pharmaceutical company reps have been visiting doctors for decades to tell them about the latest drugs. But how does the practice affect patients? A group of economists tried to answer that question.

Most violations of the Health Information Portability and Accountability Act (HIPAA) are addressed through administrative enforcement action. But, in some circumstances of improper conduct affecting ...

Academic medical centers implemented policies limiting pharmaceutical representative sales visits to physicians to assess whether these visits impact physician prescribing patterns, according to a ...

When it comes to pharma’s reputation at the end of 2022, there’s some good news and some bad news. The bad news is that according to the Harris Poll, pharma’s rep in the U.S. is continuing to drop ...

A pharmaceutical rep collapsed in the Oval Office on Thursday right as Eli Lilly‘s David Ricks was discussing a weight loss drug deal during a press conference with President Donald Trump. “A ...

Connecticut will bolster its existing prescription drug reporting and transparency regime with new requirements on pharmaceutical sales representative registration and updates to existing manufacturer ...

Representative Susan Wild took to the House floor to challenge the legitimacy of recent insulin price cuts from major pharmaceutical companies and pressure the industry to reduce costs to patients on ...